Clinical Trial Update: Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated early cryoprecipitate administration during Major Hemorrhage Protocol activation in trauma patients; results have been posted after co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Injury

Drugs mentioned

• Cryoprecipitate (cryoprecipitate)

Snippet

Sponsor: Bryan Cotton | Conditions: Trauma Injury | Phase 3 | Status: COMPLETED | Results posted: 2023-02-21